Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Z. V. Amoev"'
Autor:
M. M. Kontorshchikov, T. N. Gorshkova, E. А. Farafontova, K. N. Kontorshchikova, A. V. Alyasova, Z. V. Amoev
Publikováno v:
Medical alphabet. :36-40
Purpose of the study: to assess the state of lipid peroxidation processes in patients with kidney cancer in relation to the clinical factors of the prognosis of the disease and against the background of surgical intervention.Material and methods. For
Autor:
M. I. Volkova, A. S. Kalpinskiy, P. S. Borisov, O. I. Evsyukova, A. S. Olshanskaya, V. B. Matveev, B. Ya. Alekseev, E. V. Peganova, A. F. Nasretdinov, E. V. Lymar, E. G. Ovchinnikova, T. A. Sveklina, E. A. Usynin, A. M. Abdelgafur, E. A. Tararova, L. M. Shumova, A. S. Belenkov, I. Yu. Dolgov, N. G. Ponomareva, I. V. Evstigneeva, A. N. Ivanov, A. R. Isaev, R. V. Leonenkov, A. V. Meskikh, M. R. Mukhitova, S. A. Orlova, I. V. Teslenok, M. M. Shegurova, M. T. Aivazov, Z. V. Amoev, K. G. Babina, A. A. Vorontsova, E. V. Karabina, N. V. Kirdakova, I. E. Shumskaya, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, E. S. Lyutova, M. M. Fael, A. N Chugarova, A. S. Antipin
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 31-44 (2021)
Objective. The primary endpoint was progression-free survival; secondary endpoints included overall survival, objective response rate and duration, tumor control rate and duration, as well as safety profile of lenvatinib with everolimus in consecutiv
Autor:
V. A. Atduev, Z. K. Kushaev, D. S. Ledyaev, Yu. O. Lyubarskaya, Z. V. Amoev, V. E. Gasrataliev, G. I. Shejyhov, I. S. Shevelev
Publikováno v:
Onkourologiâ, Vol 16, Iss 4, Pp 136-146 (2021)
Objective: to study the long-term functional results of creating an orthotopic urinary reservoir from the ileocecal angle in comparison with the Studer technique of creating a urinary reservoir after radical cystectomy in women. Materials and methods
Autor:
M. I. Volkova, A. M. Abdelgafur, M. T. Aivazov, Z. V. Amoev, K. G. Babina, P. S. Borisov, A. A. Vorontsovа, I. V. Evstigneeva, O. I. Evsyukova, O. V. Zhelezin, A. S. Kalpinsky, E. V. Karabina, N. V. Kirdakova, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, R. V. Leonenkov, M. R. Maturov, A. V. Meskikh, S. V. Mishugin, E. G. Ovchinnikova, A. S. Olshanskaya, S. A. Protsenko, T. Yu. Semiglazova, R. V. Smirnov, E. A. Usynin, M. M. Fael, E. M. Cherniakova, I. E. Shumskaya
Publikováno v:
Onkourologiâ, Vol 15, Iss 3, Pp 56-69 (2019)
Objective: an assessment of efficacy and safety of lenvatinib in combination with everolimus in unselected patients with metastatic renal cell carcinoma (mRCC) progressed during or following ≥1 line of antiangiogenic targeted therapy.Material. Russ
Autor:
V. A. Atduev, V. E. Gasrataliev, D. S. Ledyaev, Z. V. Amoev, A. A. Danilov, Kh. M. Mamedov, Z. K. Kushаev, Yu. O. Lyubarskaya
Publikováno v:
Onkourologiâ, Vol 13, Iss 3, Pp 95-102 (2017)
Objective : to identify the most important factors influencing the development of complications after radical cystectomy (RCE). Materials and methods . The results of 182 RCEs performed in September 2014 and December 2016 were analyzed. The patients
Autor:
V. A. Atduev, Z. V. Amoev, A. A. Danilov, V. A. Bel’skiy, D. S. Ledyaev, P. I. Rykhtik, G. I. Sheyikhov, S. A. Puzanov
Publikováno v:
Onkourologiâ, Vol 13, Iss 1, Pp 37-44 (2017)
Objective. Analysis of factors affecting results of inferior vena cava (IVC) thrombectomy in patients with renal cell carcinoma. Materials and methods . Nephrectomy with thrombectomy from IVC was performed in 53 patients (31 (58.5 %) males and 22 (41
Autor:
V. A. Atduev, G. I. Sheiykhov, A. A. Danilov, M. B. Dyrdik, Z. V. Amoev, D. S. Ledyaev, Yu. O. Lyubarskaya, P. I. Rykhtik, I. V. Shatokhina
Publikováno v:
Onkourologiâ, Vol 13, Iss 2, Pp 20-26 (2017)
Objective . Study of 90 day complications after solitary kidney resection and determination of their dependence on resection complexity level in accordance with the RENAL nephrometry scoring system. Materials and methods . Seventy (70) resections due
Autor:
E. I. Samsonova, T. N. Gorshkova, Z. V. Amoev, E. V. Strokina, K. N. Kontorshchikova, A. V. Alyasova
Publikováno v:
Modern Technologies in Medicine
The aim of the study was to assess the possibility of using plasma levels of tumor M2-pyruvate kinase (Tu M2-PK), matrix carbonic anhydrase IX (CA9), and matrix metalloproteinase 9 (MMP9) in patients with renal cell cancer as predictors of the diseas
Autor:
V A, Atduev, Z V, Amoev, A V, Aliasova, P I, Rykhtik, S A, Puzanov, V I, Shalapuda, Iu O, Liubarskaya
Publikováno v:
Urologiia (Moscow, Russia : 1999). (4)
Results of treatment of 32 patients after nephrectomy with thrombectomy for renal cell carci-noma complicated by tumor thrombosis of the inferior vena cava were analyzed. The study in-cluded patients only with II - IV clot levels: 26 patients with T3